YK-11

YK-11 (10mg x 50)

YK-11, also known as Myostine, is a promising Selective Estrogen Receptor Modulator (SARM) that happens to be a myostatin inhibitor, and interestingly can also be classified as a steroid due to its chemical structure. On a steroidal level, it seems to behave similarly to other dihydrotestosterone (DHT) derivatives (such as Masteron, Primobolan, Anavar, etc.). As a myostatin inhibitor, it induces follistatin expression, which antagonistically inhibits muscle tissue from producing myostatin – which limits the amount of muscle tissue one can build. In animal and human studies, when myostatin has been inhibited by a genetic mutation, the test subject will build significantly more muscle tissue than those subjects with normal myostatin levels. The potential to build muscle tissue through this unique pathway of inducing follistatin expression, which inhibits myostatin (a growth differentiation factor), is something that no other steroid, SARM, or peptide can do, giving this SARM a lot of potential. YK11 is selective to muscle and bone tissue, so it was developed for clinical use as an alternative treatment to testosterone for different muscle-wasting conditions and diseases. Due to a lack of clinical studies, the efficacy of this steroidal SARM has not been proven. Selective Androgen Receptor Modulators (SARMs) are similar to anabolic-androgenic steroids (AAS) in that they are anabolic in nature and can enhance the ability to gain strength and muscle mass. Developed as an alternative to testosterone use in clinical settings for different muscle-wasting conditions/diseases, SARMs differ from traditional steroids by their mechanism of action. Where SARMs are selective to the androgen receptors primarily found in muscle and bone tissue, steroids are not selective and bind to androgen receptors in other tissues/organs. Prolonged use and/or abuse of steroids can lead to serious life-threatening conditions for this and other reasons. SARMs have fewer adverse side effects when compared to steroids, so they are considered safer, especially for women (as they are far less androgenic and do not lead to virilization), making them ideal for beginners hesitant to use traditional steroids. Most SARMs come in oral pill form, so they do not require to be injected. This does make them hepatotoxic, but generally, they are significantly less liver-toxic than most oral steroids. SARM use can still suppress natural testosterone production (depending on the dosage), so they are generally still used in conjunction with testosterone as a base compound. As SARMs are still relatively new, more research and long-term clinical studies are needed to prove their efficacy and to monitor the side effects of long-term use. So far the research and anecdotal evidence looks very promising for the future of SARMs.

Benefits:

● The only known Myostatin Inhibiting drug
● Increased potential to build muscle tissue
● Increased bone density
● Surpass your genetic potential
● Great addition to bulking & cutting cycles
● Makes muscles appear hard, and dry at a low enough body fat percentage

Half-life:

● Unknown

Possible Dosage & Cycle Length:

● Men @ 10-30 mg/day
● Split daily dosage into multiple separate doses due to the unknown half-life
● Not recommended for women
● 4-12 weeks

Related Products:

● LGD-4033, HGH, T400, RAD140